Across TCGA pan-cancer cohorts, MRPS18CP4 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MRPS18CP4’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where MRPS18CP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MRPS18CP4 is over-expressed in tumor.
THCA are the cancer types where MRPS18CP4 tumor–normal differential expression is most reproducible.